Sept. 9 (Bloomberg) -- Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.
Advanced Analogic Technologies Inc. (AATI US) fell the most in the Russell 2000 Index, slumping 22 percent to $4.62. Skyworks Solutions Inc. (SWKS US) said the maker of power-management chips for mobile phones and computers has failed to perform its obligations under their merger agreement, according to a regulatory filing.
Coca-Cola Enterprises Inc. (CCE US) declined 6 percent, the most since Aug. 8, to $25.34. The bottler said it made a mistake in threatening to reconsider a 17 million-euro ($24 million) manufacturing investment in southern France because of a sugar-related tax proposal.
Corning Inc. (GLW US) slipped 5.4 percent to $13.58, the lowest price since Aug. 10. The maker of glass for flat-panel televisions had its share-price estimate cut to $14.50 from $17.50 by JPMorgan Chase & Co., which cited lower-than-expected glass sales.
Hurco Cos. (HURC US) advanced 9.1 percent, the most since Aug. 23, to $25.76. The computer controller designer posted third-quarter earnings of 70 cents a share on revenue of $50.6 million and said it is beginning to see the “reward” from investments in China and India.
Kroger Co. (KR US) slumped 5.7 percent, the most since Dec. 2, to $22.02. The largest U.S. grocery-store chain said on a conference call that rising product costs continue to affect all parts of its business.
Rival Safeway Inc. (SWY US) fell 4.2 percent to $17.91.
Lazard Ltd. (LAZ US) declined 5.1 percent to $24.48, the lowest level since March 2009. The biggest non-bank merger adviser was cut to “neutral” from “buy” at Ticonderoga Securities LLC., which cited a slower recovery in mergers and acquisitions.
Regeneron Pharmaceuticals Inc. (REGN US) sank 9.1 percent, the most since April 29, to $65.62. The drugmaker was cut to “underperform” from “neutral” at Bank of America Corp. The Tarrytown, New York-based company was also lowered to “market perform” from “outperform” at Leerink Swann & Co., which cited the need for improved visibility on the launch of its blindness drug Eylea.
Ulta Salon Cosmetics & Fragrance Inc. (ULTA US) increased 15 percent to $68.45, the biggest gain in the Russell 1000 Index. The beauty-products retailer reported second-quarter earnings excluding some items of 38 cents a share, exceeding the average analyst estimate of 32 cents.
VeriSign Inc. (VRSN US) sank 15 percent, the largest decline in the S&P 500, to $29. The operator of computers that direct Internet traffic announced the departure of Chief Financial Officer Brian Robins, squelching speculation that it was poised to be acquired.
To contact the reporter responsible for this story: Lu Wang in New York at firstname.lastname@example.org.
To contact the editor responsible for this story: Nick Baker at email@example.com